Cargando…
VEGF and Intraocular Neovascularization: From Discovery to Therapy
I am honored and humbled to be one of the awardees of the 2014 A. Champalimaud Vision Award. I offer my heartfelt thanks to the Champalimaud Foundation President, Leonor Beleza, and to the Award Committee Members for this wonderful recognition. I feel especially fortunate to have had the opportunity...
Autor principal: | Ferrara, Napoleone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790412/ https://www.ncbi.nlm.nih.gov/pubmed/26981332 http://dx.doi.org/10.1167/tvst.5.2.10 |
Ejemplares similares
-
Heparin-binding VEGFR1 variants as long-acting VEGF inhibitors for treatment of intraocular neovascular disorders
por: Xin, Hong, et al.
Publicado: (2021) -
VEGF: From Discovery to Therapy: The Champalimaud Award Lecture
por: Miller, Joan W.
Publicado: (2016) -
Vascular heterogeneity: VEGF receptors make blood vessels special
por: Li, Pin, et al.
Publicado: (2022) -
Recent advances and future directions for the pharmacogenetic basis of anti-VEGF treatment response in neovascular age-related macular degeneration
por: Riaz, Moeen, et al.
Publicado: (2017) -
New Therapies of Neovascular AMD—Beyond Anti-VEGFs
por: Yerramothu, Praveen
Publicado: (2018)